Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of Astrana Health, Inc. from Q4 2009 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary: Astrana Health, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q4 2009 to Q3 2025.
Astrana Health, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2025 was $789,075,000, a 11.2% increase year-over-year.
Source SEC data: View on sec.gov

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

Astrana Health, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$789,075,000	+$79,456,000	+11.2%	30 Sep 2025	10-Q	10 Nov 2025	2025	Q3
Q2 2025	$771,528,000	+$88,520,000	+13%	30 Jun 2025	10-Q	10 Nov 2025	2025	Q3
Q1 2025	$750,439,000	+$92,464,000	+14.1%	31 Mar 2025	10-Q	10 Nov 2025	2025	Q3
Q4 2024	$716,726,000	+$100,075,000	+16.2%	31 Dec 2024	10-Q	10 Nov 2025	2025	Q3
Q3 2024	$709,619,000	+$111,910,000	+18.7%	30 Sep 2024	10-Q	10 Nov 2025	2025	Q3
Q2 2024	$683,008,000	+$113,255,000	+19.9%	30 Jun 2024	10-Q	10 Nov 2025	2025	Q3
Q1 2024	$657,975,000	+$106,968,000	+19.4%	31 Mar 2024	10-Q	10 Nov 2025	2025	Q3
Q4 2023	$616,651,000	+$72,341,000	+13.3%	31 Dec 2023	10-Q	10 Nov 2025	2025	Q3
Q3 2023	$597,709,000	+$93,336,000	+18.5%	30 Sep 2023	10-Q	12 Nov 2024	2024	Q3
Q2 2023	$569,753,000	+$90,240,000	+18.8%	30 Jun 2023	10-Q	12 Nov 2024	2024	Q3
Q1 2023	$551,007,000	+$78,369,000	+16.6%	31 Mar 2023	10-Q	12 Nov 2024	2024	Q3
Q4 2022	$544,310,000	+$90,203,000	+19.9%	31 Dec 2022	10-K	14 Mar 2025	2024	FY
Q3 2022	$504,373,000	+$64,052,000	+14.5%	30 Sep 2022	10-Q	09 Nov 2023	2023	Q3
Q2 2022	$479,513,000	+$74,931,000	+18.5%	30 Jun 2022	10-Q	09 Nov 2023	2023	Q3
Q1 2022	$472,638,000	+$122,951,000	+35.2%	31 Mar 2022	10-Q	09 Nov 2023	2023	Q3
Q4 2021	$454,107,000	+$124,644,000	+37.8%	31 Dec 2021	10-K	14 Mar 2025	2024	FY
Q3 2021	$440,321,000	+$210,903,000	+91.9%	30 Sep 2021	10-Q	07 Nov 2022	2022	Q3
Q2 2021	$404,582,000	+$196,734,000	+94.7%	30 Jun 2021	10-Q	07 Nov 2022	2022	Q3
Q1 2021	$349,687,000	+$151,726,000	+76.6%	31 Mar 2021	10-Q	07 Nov 2022	2022	Q3
Q4 2020	$329,463,000	+$137,128,000	+71.3%	31 Dec 2020	10-K	29 Feb 2024	2023	FY
Q3 2020	$229,418,000	+$37,244,000	+19.4%	30 Sep 2020	10-Q	05 Nov 2021	2021	Q3
Q2 2020	$207,848,000	+$21,759,000	+11.7%	30 Jun 2020	10-Q	05 Nov 2021	2021	Q3
Q1 2020	$197,961,000	+$15,584,000	+8.54%	31 Mar 2020	10-Q	05 Nov 2021	2021	Q3
Q4 2019	$192,335,000	+$10,790,000	+5.94%	31 Dec 2019	10-K/A	09 Aug 2023	2022	FY
Q3 2019	$192,174,000	+$7,047,331	+3.81%	30 Sep 2019	10-Q	09 Nov 2020	2020	Q3
Q2 2019	$186,089,000	+$11,273,844	+6.45%	30 Jun 2019	10-Q	09 Nov 2020	2020	Q3
Q1 2019	$182,377,000	+$11,888,857	+6.97%	31 Mar 2019	10-Q	09 Nov 2020	2020	Q3
Q4 2018	$181,545,000	+$17,362,000	+10.6%	31 Dec 2018	10-K	28 Feb 2022	2021	FY
Q3 2018	$185,126,669	+$192,418,219		30 Sep 2018	10-Q	08 Nov 2019	2019	Q3
Q2 2018	$174,815,156	+$178,154,276		30 Jun 2018	10-Q	08 Nov 2019	2019	Q3
Q1 2018	$170,488,143	+$170,217,775		31 Mar 2018	10-Q	08 Nov 2019	2019	Q3
Q4 2017	$164,183,000	+$76,595,280	+87.4%	31 Dec 2017	10-K	15 Mar 2021	2020	FY
Q3 2017	$-7,291,550	-$6,010,684	-469%	30 Sep 2017	10-Q	14 Nov 2017	2018	Q2
Q2 2017	$-3,339,120	-$3,842,969	-763%	30 Jun 2017	10-Q	14 Aug 2017	2018	Q1
Q1 2017	$270,368^*	-$1,203,140		31 Mar 2017	10-Q	14 Nov 2017	2018	Q2
Q4 2016	$87,587,720	+$3,088,688	+3.66%	31 Dec 2016	10-K	16 Mar 2020	2019	FY
Q3 2016	$-1,280,866	+$2,676,333	+67.6%	30 Sep 2016	10-Q	14 Nov 2016	2017	Q2
Q2 2016	$503,849	+$4,236,107		30 Jun 2016	10-Q	15 Aug 2016	2017	Q1
Q1 2016	$1,473,508	+$2,463,692		31 Mar 2016	10-K	29 Jun 2017	2017	FY
Q4 2015	$84,499,032	+$85,970,773		31 Dec 2015	10-K	02 Apr 2018	2017	FY
Q3 2015	$-3,957,199	-$3,453,174	-685%	30 Sep 2015	10-Q	17 Nov 2015	2016	Q2
Q2 2015	$-3,732,258	-$739,297	-24.7%	30 Jun 2015	10-Q	28 Aug 2015	2016	Q1
Q1 2015	$-990,184	+$632,971	+39%	31 Mar 2015	10-K	29 Jun 2017	2017	FY
Q4 2014	$-1,471,741	+$220,977	+13.1%	31 Dec 2014	10-Q	23 Feb 2015	2015	Q3
Q3 2014	$-504,025	+$542,213	+51.8%	30 Sep 2014	10-Q	14 Nov 2014	2015	Q2
Q2 2014	$-2,992,961	-$1,723,500	-136%	30 Jun 2014	10-Q	14 Aug 2014	2015	Q1
Q1 2014	$-1,623,155	-$688,236	-73.6%	31 Mar 2014	10-K	29 Jun 2016	2016	FY
Q4 2013	$-1,692,718	-$1,301,339	-333%	31 Jan 2014	10-K	14 Jul 2015	2015	FY
Q3 2013	$-1,046,238	-$967,651		31 Oct 2013	10-Q	20 Dec 2013	2013	Q3
Q2 2013	$-1,269,461	+$2,338,646	+64.8%	31 Jul 2013	10-Q	16 Sep 2013	2013	Q2
Q1 2013	$-934,919	-$478,662	-105%	30 Apr 2013	10-Q	14 Jun 2013	2013	Q1
Q4 2012	$-391,379	+$29,841	+7.08%	31 Jan 2013	10-K	14 Jul 2015	2015	FY
Q3 2012	$-78,587^*	-$101,819		31 Oct 2012	10-Q	17 Dec 2012	2012	Q3
Q2 2012	$-3,608,107	+$143,682,893	+97.6%	31 Jul 2012	10-Q	14 Sep 2012	2012	Q2
Q1 2012	$-456,257			30 Apr 2012	10-Q	19 Jun 2012	2012	Q1
Q4 2011	$-421,220	-$338,027		31 Jan 2012	10-K	08 May 2014	2013	FY
Q3 2011	$23,232^*			31 Oct 2011	10-Q/A	10 Apr 2012	2011	Q3
Q2 2011	$-147,291,000			31 Jul 2011	10-Q/A	10 Apr 2012	2011	Q2
Q4 2010	$-83,193^*	-$36,800		31 Jan 2011	10-K	01 May 2013	2012	FY
Q4 2009	$-46,393^*			31 Jan 2010	10-K	15 May 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.